CCPA imposes penalty on Sensodyne for misleading advertisements
- Blog|News|Competition Law|
- 2 Min Read
- By Taxmann
- |
- Last Updated on 23 March, 2022
Latest from Taxmann
Press release, Dated: 22.03.2022
The Central Consumer Protection Authority (CCPA) has passed an order imposing a penalty of Rs. 10 lakhs against Sensodyne for misleading advertisements of its products whereby it had made claims such as “Recommended by dentists worldwide” and “World’s No.1 sensitivity toothpaste”. Earlier on 09.02.2022, the CCPA had passed an order directing discontinuation of advertisement of Sensodyne products which show endorsement by foreign dentists.
CCPA had initiated suo-moto action against the advertisement of Sensodyne products on various platforms including Television, YouTube, Facebook, and Twitter showing dentists practicing outside India (practicing in the United Kingdom) endorsing the use of Sensodyne products namely Sensodyne Rapid Relief and Sensodyne Fresh Gel for protection against teeth sensitivity and making different claims including the claim that toothpaste is “clinically proven relief, works in 60 seconds”.
With respect to the claim, CCPA had written to the Drugs Controller General of India, Central Drugs Standard Control Organization (CDSCO) to furnish its comments on the correctness of the claims made by the company.
CDSCO directed The Assistant Drug Controller, Licensing Authority, Silvassa to investigate the claims made by the company. Accordingly, the Assisting Drug Controller has written to CCPA stating that the claims made by the company are under investigation and further action will be initiated after the hearing process.
CCPA has also issued two Safety Notices u/s 18(2)(j) of the Act alerting consumers against buying goods that do not hold without valid ISI Mark and violate the BIS standards directed for compulsory use by the Govt.
Further, to safeguard consumer interest against misleading advertisements and unfair trade practices, CCPA has also issued two advisories. The first advisory was issued on 20.01.2021 to cease making misleading claims that take advantage of the Covid-19 pandemic situation and the second was issued on 01.10.2021 highlighting compliance of the provisions of Consumer Protection (e-commerce) Rules, 2020 which required every marketplace e-commerce entity to display all information provided to it by seller under Rule 6(5) including name, designation and contact information of the grievance officer of the seller
Click Here To Read The Full News
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.
Taxmann Publications has a dedicated in-house Research & Editorial Team. This team consists of a team of Chartered Accountants, Company Secretaries, and Lawyers. This team works under the guidance and supervision of editor-in-chief Mr Rakesh Bhargava.
The Research and Editorial Team is responsible for developing reliable and accurate content for the readers. The team follows the six-sigma approach to achieve the benchmark of zero error in its publications and research platforms. The team ensures that the following publication guidelines are thoroughly followed while developing the content:
- The statutory material is obtained only from the authorized and reliable sources
- All the latest developments in the judicial and legislative fields are covered
- Prepare the analytical write-ups on current, controversial, and important issues to help the readers to understand the concept and its implications
- Every content published by Taxmann is complete, accurate and lucid
- All evidence-based statements are supported with proper reference to Section, Circular No., Notification No. or citations
- The golden rules of grammar, style and consistency are thoroughly followed
- Font and size that’s easy to read and remain consistent across all imprint and digital publications are applied
One thought on “CCPA imposes penalty on Sensodyne for misleading advertisements”
Leave a Reply
Sign Up
To subscribe to our weekly newsletter please log in/register on Taxmann.com
Latest Books
Everything on Tax and Corporate Laws of India
To subscribe to our weekly newsletter please log in/register on Taxmann.com
How and where can one access Orders passed by the CCPA?